SHAWNEE, Kan. – Bayer announced its purchase of Boehringer Ingelheim Vetmedica's Cydectin bovine and ovine endectocide products in the US. This will be Bayer’s first venture into farm animal endectocide and livestock insecticides.
"We are pleased to announce the addition of the Cydectin products into the Bayer Animal Health portfolio,” said Joyce J. Lee, Bayer’s president of commercial operations for animal health, North America. “This transaction underlines a significant milestone for Bayer as we commit to strengthen and invest in our Animal Health business through external opportunities.”
The acquisition includes the transfer of Cydectin Pour-On, Cydectin Injectable and Cydectin Oral Drench.
These endectocides, with the active ingredient moxidectin, kill internal parasites at multiple stages, including the brown stomach worm parasite. It also controls external parasites including lice, grubs and psoroptic mange mites on beef and dairy cattle.
“The Cydectin product line will enable Bayer to offer veterinarians and cattle producers more robust insecticide solutions to meet their needs in a dynamic environment,” Lee adds. “The integration success of these products into our customer offerings is a key priority for Bayer.”
